(Editors' Note: This article covers a micro-cap stock. Please be aware of the risks associated with these stocks.)
Today's article features Aeterna Zentaris (NASDAQ:AEZS), one of the most undervalued biotech companies in the market. This is a small $1 biotech stock which has fallen out of favor with almost all investors. A look at the chart explains why. While the broader biotech indices rallied sharply, Aeterna lost 90% of its market capitalization. This marks a widespread volatility in the sector but also enhances, as we like to elaborate in this article, the opportunity to discover deeply undervalued micro-caps. Selling of this magnitude often pushes shares down to an irrationally low level, creating huge buying opportunities. Aeterna has all...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|